id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0745-0053,FDA,FDA-2013-N-0745,"Reopening of Docket and Request for Comments on the Food and Drug
Administration Safety and Innovation Act Action Plan",Notice,Request for Comments,2014-08-22T04:00:00Z,2014,8,2014-08-22T04:00:00Z,2014-10-22T03:59:59Z,2015-01-27T16:02:22Z,2014-19881,0,0,090000648183b320
FDA-2013-N-0745-0022,FDA,FDA-2013-N-0745,"Action Plan for the Collection, Analysis, and Availability of Demographic Subgroup Data in Applications for Approval of Food and Drug Administration-Regulated Medical Products; Notice of Public
Hearing; Request for Comments",Proposed Rule,Notice of Hearing,2014-03-04T05:00:00Z,2014,3,2014-03-04T05:00:00Z,2014-05-17T03:59:59Z,2014-05-18T01:02:23Z,2014-04625,0,0,09000064815f6b9f
FDA-2013-N-0745-0001,FDA,FDA-2013-N-0745,Request for Comments on the Food and Drug Administration Safety and Innovation Act Section 907 Report,Notice,General Notice,2013-08-22T04:00:00Z,2013,8,2013-08-22T04:00:00Z,2013-11-21T04:59:59Z,2014-01-14T15:09:51Z,2013-20352,0,0,09000064813bf052